Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All molnupiravir studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchMolnupiravirMolnupiravir (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   All Outcomes    Recent:   

Molnupiravir: coding for catastrophe

Malone et al., Nature Structural & Molecular Biology, doi:10.1038/s41594-021-00657-8
Sep 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Review of recent studies on molnupiravir's mechanism of lethal mutagenesis. Authors note that potential off-target effects require further investigation, because molnupiravir may be mutagenic to host DNA during host DNA replication.
Reviews covering molnupiravir for COVID-19 include1-8.
Malone et al., 13 Sep 2021, peer-reviewed, 2 authors.
This PaperMolnupiravirAll
news & views
Antiviral Therapeutics, Brandon Malone, Elizabeth A Campbell
Molnupiravir: coding for catastrophe Molnupiravir, a wide-spectrum antiviral that is currently in phase 2/3 clinical trials for the treatment of COVID-19, is proposed to inhibit viral replication by a mechanism known as 'lethal mutagenesis'. Two recently published studies reveal the biochemical and structural bases of how molnupiravir disrupts the fidelity of SARS-CoV-2 genome replication and prevents viral propagation by fostering error accumulation in a process referred to as 'error catastrophe'.
Competing interests The authors declare no competing interests. Is it a wrap? Nucleosome interactions of the BRCA1-binding partner, BARD1, steal the scene emerging findings provide compelling evidence that the bRCA1-binding partner bARD1 contributes yet further to bRCA1 function. bARD1 is crucial for positioning the e2 ubiquitin-conjugating enzyme that confers specificity of its ligase to residues on histone H2A, and bARD1 also promotes DNA damage-induced chromatin recruitment through an interaction with ubiquitin-conjugated Lys13 or Lys15 of H2A on the nucleosome core particle. Nature Joanna R. Morris T he BRCA1-BARD1 complex is a crucial tumor suppressor that is linked to the prevention of familial breast and ovarian cancers. The heterodimer has several proposed functions, including the regulation of DNA resection and the promotion of RAD51 loading through PALB2-BRCA2, which is required for homology-directed DNA repair. Despite the tremendous focus in the decades since the discovery of the BRCA1 gene, several critical questions have remained, if not completely unanswered, then with unsatisfactory solutions. Although a complete literature review is not possible here, some pertinent observations are that recruitment of BRCA1-BARD1 to damaged chromatin occurs through the
References
Agostini, None, J. Virol
Bouvet, Proc. Natl Acad. Sci
Gordon, None, J. Biol. Chem
Gordon, Tchesnokov, Schinazi, Götte, None, J. Biol. Chem
Hall, None, J. Infect. Dis, doi:10.1093/infdis/jiab305
Jena, None, Phys. Chem. Chem. Phys. PCCP
Kabinger, None, Nat. Struct. Mol. Biol, doi:10.1038/s41594-021-00651-0
Sheahan, None, Sci. Transl. Med
Smith, Blanc, Vignuzzi, Denison, None, PLOS Pathog
Sticher, None, Antimicrob. Agents Chemother
Toots, None, Sci. Transl. Med
Urakova, None, J. Virol
Vicenti, Zazzi, Saladini, None, Expert Opin. Ther. Pat
Wahl, None, Nature
Yoon, None, Antimicrob. Agents Chemother
Zhou, None, J. Infect. Dis, doi:10.1093/infdis/jiab2
{ 'indexed': {'date-parts': [[2024, 5, 14]], 'date-time': '2024-05-14T09:44:28Z', 'timestamp': 1715679868901}, 'reference-count': 16, 'publisher': 'Springer Science and Business Media LLC', 'issue': '9', 'license': [ { 'start': { 'date-parts': [[2021, 9, 1]], 'date-time': '2021-09-01T00:00:00Z', 'timestamp': 1630454400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}, { 'start': { 'date-parts': [[2021, 9, 1]], 'date-time': '2021-09-01T00:00:00Z', 'timestamp': 1630454400000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2021, 9]]}, 'DOI': '10.1038/s41594-021-00657-8', 'type': 'journal-article', 'created': {'date-parts': [[2021, 9, 13]], 'date-time': '2021-09-13T16:03:30Z', 'timestamp': 1631549010000}, 'page': '706-708', 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 114, 'title': 'Molnupiravir: coding for catastrophe', 'prefix': '10.1038', 'volume': '28', 'author': [ {'given': 'Brandon', 'family': 'Malone', 'sequence': 'first', 'affiliation': []}, {'given': 'Elizabeth A.', 'family': 'Campbell', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2021, 9, 13]]}, 'reference': [ { 'key': '657_CR1', 'doi-asserted-by': 'publisher', 'unstructured': 'Hall, M. D. et al. J. Infect. Dis. ' 'https://doi.org/10.1093/infdis/jiab305 (2021).', 'DOI': '10.1093/infdis/jiab305'}, { 'key': '657_CR2', 'doi-asserted-by': 'publisher', 'first-page': '100770', 'DOI': '10.1016/j.jbc.2021.100770', 'volume': '297', 'author': 'CJ Gordon', 'year': '2021', 'unstructured': 'Gordon, C. J., Tchesnokov, E. P., Schinazi, R. F. & Götte, M. J. Biol. ' 'Chem. 297, 100770 (2021).', 'journal-title': 'J. Biol. Chem.'}, { 'key': '657_CR3', 'doi-asserted-by': 'publisher', 'unstructured': 'Kabinger, F. et al. Nat. Struct. Mol. Biol. ' 'https://doi.org/10.1038/s41594-021-00651-0 (2021).', 'DOI': '10.1038/s41594-021-00651-0'}, { 'key': '657_CR4', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1080/13543776.2021.1880568', 'volume': '31', 'author': 'I Vicenti', 'year': '2021', 'unstructured': 'Vicenti, I., Zazzi, M. & Saladini, F. Expert Opin. Ther. Pat. 31, 1–13 ' '(2021).', 'journal-title': 'Expert Opin. Ther. Pat.'}, { 'key': '657_CR5', 'doi-asserted-by': 'publisher', 'first-page': '6785', 'DOI': '10.1074/jbc.RA120.013679', 'volume': '295', 'author': 'CJ Gordon', 'year': '2020', 'unstructured': 'Gordon, C. J. et al. J. Biol. Chem. 295, 6785–6797 (2020).', 'journal-title': 'J. Biol. Chem.'}, { 'key': '657_CR6', 'doi-asserted-by': 'publisher', 'first-page': 'e00766', 'DOI': '10.1128/AAC.00766-18', 'volume': '62', 'author': 'J-J Yoon', 'year': '2018', 'unstructured': 'Yoon, J.-J. et al. Antimicrob. Agents Chemother. 62, e00766 (2018).', 'journal-title': 'Antimicrob. Agents Chemother.'}, { 'key': '657_CR7', 'doi-asserted-by': 'publisher', 'first-page': 'e01348', 'DOI': '10.1128/JVI.01348-19', 'volume': '93', 'author': 'ML Agostini', 'year': '2019', 'unstructured': 'Agostini, M. L. et al. J. Virol. 93, e01348 (2019).', 'journal-title': 'J. Virol.'}, { 'key': '657_CR8', 'doi-asserted-by': 'publisher', 'first-page': 'eabb5883', 'DOI': '10.1126/scitranslmed.abb5883', 'volume': '12', 'author': 'TP Sheahan', 'year': '2020', 'unstructured': 'Sheahan, T. P. et al. Sci. Transl. Med. 12, eabb5883 (2020).', 'journal-title': 'Sci. Transl. Med.'}, { 'key': '657_CR9', 'doi-asserted-by': 'publisher', 'first-page': 'e01965', 'DOI': '10.1128/JVI.01965-17', 'volume': '92', 'author': 'N Urakova', 'year': '2018', 'unstructured': 'Urakova, N. et al. J. Virol. 92, e01965–17 (2018).', 'journal-title': 'J. Virol.'}, { 'key': '657_CR10', 'doi-asserted-by': 'publisher', 'first-page': '451', 'DOI': '10.1038/s41586-021-03312-w', 'volume': '591', 'author': 'A Wahl', 'year': '2021', 'unstructured': 'Wahl, A. et al. Nature 591, 451–457 (2021).', 'journal-title': 'Nature'}, { 'key': '657_CR11', 'doi-asserted-by': 'publisher', 'first-page': '9372', 'DOI': '10.1073/pnas.1201130109', 'volume': '109', 'author': 'M Bouvet', 'year': '2012', 'unstructured': 'Bouvet, M. et al. Proc. Natl Acad. Sci. 109, 9372–9377 (2012).', 'journal-title': 'Proc. Natl Acad. Sci.'}, { 'key': '657_CR12', 'doi-asserted-by': 'publisher', 'first-page': 'e1003565', 'DOI': '10.1371/journal.ppat.1003565', 'volume': '9', 'author': 'EC Smith', 'year': '2013', 'unstructured': 'Smith, E. C., Blanc, H., Vignuzzi, M. & Denison, M. R. PLOS Pathog. 9, ' 'e1003565 (2013).', 'journal-title': 'PLOS Pathog.'}, { 'key': '657_CR13', 'doi-asserted-by': 'publisher', 'first-page': '28115', 'DOI': '10.1039/D0CP05297C', 'volume': '22', 'author': 'NR Jena', 'year': '2020', 'unstructured': 'Jena, N. R. Phys. Chem. Chem. Phys. PCCP 22, 28115–28122 (2020).', 'journal-title': 'Phys. Chem. Chem. Phys. PCCP'}, { 'key': '657_CR14', 'doi-asserted-by': 'publisher', 'first-page': 'eaax5866', 'DOI': '10.1126/scitranslmed.aax5866', 'volume': '11', 'author': 'M Toots', 'year': '2019', 'unstructured': 'Toots, M. et al. Sci. Transl. Med. 11, eaax5866 (2019).', 'journal-title': 'Sci. Transl. Med.'}, { 'key': '657_CR15', 'doi-asserted-by': 'publisher', 'first-page': 'e01719', 'DOI': '10.1128/AAC.01719-19', 'volume': '64', 'author': 'ZM Sticher', 'year': '2020', 'unstructured': 'Sticher, Z. M. et al. Antimicrob. Agents Chemother. 64, e01719 (2020).', 'journal-title': 'Antimicrob. Agents Chemother.'}, { 'key': '657_CR16', 'doi-asserted-by': 'publisher', 'unstructured': 'Zhou, S. et al. J. Infect. Dis. https://doi.org/10.1093/infdis/jiab2 ' '(2021).', 'DOI': '10.1093/infdis/jiab2'}], 'container-title': 'Nature Structural & Molecular Biology', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://www.nature.com/articles/s41594-021-00657-8.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://www.nature.com/articles/s41594-021-00657-8', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://www.nature.com/articles/s41594-021-00657-8.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 10, 12]], 'date-time': '2021-10-12T10:49:48Z', 'timestamp': 1634035788000}, 'score': 1, 'resource': {'primary': {'URL': 'https://www.nature.com/articles/s41594-021-00657-8'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 9]]}, 'references-count': 16, 'journal-issue': {'issue': '9', 'published-print': {'date-parts': [[2021, 9]]}}, 'alternative-id': ['657'], 'URL': 'http://dx.doi.org/10.1038/s41594-021-00657-8', 'relation': {}, 'ISSN': ['1545-9993', '1545-9985'], 'subject': [], 'container-title-short': 'Nat Struct Mol Biol', 'published': {'date-parts': [[2021, 9]]}, 'assertion': [ { 'value': '13 September 2021', 'order': 1, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '11 October 2021', 'order': 2, 'name': 'change_date', 'label': 'Change Date', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': 'Correction', 'order': 3, 'name': 'change_type', 'label': 'Change Type', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': 'A Correction to this paper has been published:', 'order': 4, 'name': 'change_details', 'label': 'Change Details', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': 'https://doi.org/10.1038/s41594-021-00683-6', 'URL': 'https://doi.org/10.1038/s41594-021-00683-6', 'order': 5, 'name': 'change_details', 'label': 'Change Details', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': 'The authors declare no competing interests.', 'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Competing interests'}}, { 'value': 'This content has been made available to all.', 'name': 'free', 'label': 'Free to read'}]}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit